CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 209 enrolled
Drug / intervention
Transluminal viscoelastic delivery and trabeculotomydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03861169
NCT03861169N/ACompleted
CompareCT.gov

Prospective, Multi-Center, Single-Arm Post-Market Study of Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma

Sight Sciences, Inc.·interventional·Posted Mar 4, 2019·Updated Aug 14, 2024

In Brief

A clinical study evaluating Transluminal viscoelastic delivery and trabeculotomy for Open Angle Glaucoma. Completed, enrolled 209 participants across 15 sites.

Detailed Summary

This study will prospectively assess the clinical effect of ab-interno transluminal viscoelastic delivery and trabeculotomy performed using the OMNI Surgical System in combination with Cataract Extraction on intraocular pressure (IOP) and the use of IOP-lowering medications in patients with mild-moderate open angle glaucoma (OAG).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpen Angle Glaucoma
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 4, 2019
Enrollment StartMar 11, 2019
Primary CompletionMay 4, 2021
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 7.3 years ago

Interventions

Transluminal viscoelastic delivery and trabeculotomydevice

Ab-interno transluminal viscoelastic delivery and trabeculotomy using OMNI Surgical System